全球神经刺激设备市场规模、份额、成长分析，按类型（植入式装置和非植入式装置）、按应用（疼痛管理和帕金森氏症）- 2024-2031 年产业预测

Global Neurostimulation Devices Market Size, Share, Growth Analysis, By Type(Implantable Devices and Non-Implantable Devices), By Application(Pain Management and Parkinson's Disease) - Industry Forecast 2024-2031

出版日期: 2024年03月27日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球神经刺激设备市场规模预估为53亿美元，预计将从2023年的59.8亿美元成长到2031年的156.7亿美元，预测期间（2024-2031年）复合年增长率为12.80%。

在多种因素的推动下，神经刺激设备市场正在经历强劲成长。其中包括人口老化、先进产品的引入、对附加治疗的需求不断增加以及偏头痛和癫痫等慢性疾病的增加。此外，这些疾病领域的医疗需求未被满足，加上神经系统疾病和生活方式相关疾病的流行，都有助于市场扩张。用于研发的外部资金以及对微创手术的需求进一步推动了这一成长。根据美国神经病学会的数据，中风和阿兹海默症是美国最主要的死亡原因之一，而帕金森氏症每年影响大量美国人。随着神经系统疾病发病率的上升，对神经刺激设备的需求预计将持续增加。製造商正在大力投资研发，重点关注植入式神经刺激设备等先进产品，预计这些产品将推动市场成长。此外，神经刺激装置植入的侵入性较小，可缩短住院时间和加速復原时间，并有望为市场开闢新的成长途径。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Medtronic (Ireland)
Abbott Laboratories (US)
Boston Scientific Corporation (US)
LivaNova PLC (UK)
Nevro Corp. (US)
NeuroPace, Inc. (US)
Synapse Biomedical Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
St. Jude Medical, Inc. (US)
Cogentix Medical, Inc. (US)
NDI Medical LLC (US)
Stimwave Technologies (US)
BioControl Medical (Israel)
EndoStim (US)
EnteroMedics (US)
Aleva Neurotherapeutics (Switzerland)
SPR Therapeutics (US)
electroCore, Inc. (US)
Soterix Medical Inc. (US)

简介目录

Product Code: SQMIG35B2087

Global Neurostimulation Devices Market size was valued at USD 5.3 Billion in 2022 and is poised to grow from USD 5.98 Billion in 2023 to USD 15.67 Billion by 2031, at a CAGR of 12.80% during the forecast period (2024-2031).

The neurostimulation device market is experiencing robust growth driven by various factors. These include an aging population, the introduction of advanced products, increasing demand for add-on therapy, and a rise in chronic diseases like migraine and epilepsy. Additionally, high unmet medical needs in these disease segments, coupled with the prevalence of neurological disorders and lifestyle-related diseases, contribute to market expansion. External funding for research and development, along with the demand for minimally invasive surgeries, further fuel this growth. According to the American Academy of Neurology, stroke and Alzheimer's rank among the leading causes of death in the United States, while Parkinson's disease affects a significant number of Americans annually. With the rising incidence of neurological diseases, the demand for neurostimulation devices is projected to escalate. Manufacturers are heavily investing in research and development, focusing on advanced products like implantable neurostimulation devices, which are anticipated to propel market growth. Moreover, the less invasive nature of neurostimulation device implantation, leading to shorter hospital stays and quicker recovery times, is poised to open up new growth avenues for the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurostimulation Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurostimulation Devices Market Segmental Analysis

Global Neurostimulation Devices market is segmented by type, Application, and region. Based on type, the market can be segmented into implantable devices and non-implantable devices. Based on Application, the market is segmented into pain management, and Parkinson's disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurostimulation Devices Market

The escalating occurrence of neurological disorders globally serves as a primary catalyst for the growth of the neurostimulation devices market. With neurological disorders, including Parkinson's disease, epilepsy, and chronic pain, imposing a substantial burden of disease worldwide, millions of individuals are affected, as highlighted by the World Health Organization. This burgeoning prevalence underscores the escalating demand for neurostimulation devices as a viable treatment solution. Consequently, manufacturers are channeling investments into research and development endeavors aimed at innovating advanced neurostimulation devices, thus contributing to the anticipated expansion of the market.

Restraints in the Global Neurostimulation Devices Market

Despite the increasing need for neurostimulation devices, their steep prices continue to pose a significant obstacle to market expansion. The high cost places a considerable financial strain on patients, particularly those residing in low- and middle-income nations. Moreover, the scarcity of proficient healthcare practitioners and the restricted accessibility of these devices in certain areas further stifle market progression. Additionally, the potential hazards linked with device implantation, including infection and malfunction, could also hinder market advancement.

Market Trends of the Global Neurostimulation Devices Market

A prominent trend in the neurostimulation devices market is the advancement of minimally invasive and non-invasive technologies, which are increasingly favored for their benefits over conventional surgical methods such as decreased pain, shorter hospital stays, and quicker recovery. Furthermore, the emergence of wireless and implantable devices is contributing to market expansion by providing patients with enhanced comfort and convenience without the need for external wires or bulky devices. This shift towards less invasive neurostimulation technologies is projected to persist, driving further market growth in the foreseeable future.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Neurostimulation Devices Market by Type

Market Overview
Implantable Devices and Non-Implantable Devices

Global Neurostimulation Devices Market by Application

Market Overview
Pain Management and Parkinson's Disease

Global Neurostimulation Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Jude Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cogentix Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NDI Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stimwave Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioControl Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EndoStim (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EnteroMedics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SPR Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
electroCore, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments